These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 335702)

  • 41. Renal osteodystrophy in course of periodic dialysis for chronic uremia.
    Kim D; Bell NH; Bundesen W; Putong P; Simon NM; Walker C; Del Greco F
    Trans Am Soc Artif Intern Organs; 1968; 14():367-71. PubMed ID: 5701557
    [No Abstract]   [Full Text] [Related]  

  • 42. Can renal bone disease be prevented?
    Shaldon S
    Proc Eur Dial Transplant Assoc; 1973; 10(0):91-123. PubMed ID: 4808119
    [No Abstract]   [Full Text] [Related]  

  • 43. Uremic bone disease: current knowledge, controversial issues, and new horizons.
    Malluche HH; Monier-Faugere MC
    Miner Electrolyte Metab; 1991; 17(4):281-96. PubMed ID: 1813791
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal osteodystrophy in children with end-stage kidney failure.
    Chan JC
    Va Med; 1979 May; 106(5):384-90. PubMed ID: 463255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pathogenesis of osteopathy in chronic renal insufficiency].
    Vel'tishchev IuE
    Pediatriia; 1974 Feb; (2):66-70. PubMed ID: 4619427
    [No Abstract]   [Full Text] [Related]  

  • 46. [Bone metabolism markers and bone histomorphometry in children with chronic renal failure in predialysis period during growth hormone treatment].
    Pańczyk-Tomaszewska M; Ziółkowska H; Debiński A; Sawicki A; Zurowska A; Pietrzyk JA; Roszkowska-Blaim M
    Pol Merkur Lekarski; 2000 Apr; 8(46):264-5. PubMed ID: 10897642
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Aluminum associated bone disease in patients undergoing long-term hemodialysis].
    Hino M; Yamamoto I; Shigeno C; Aoki J; Torizuka K; Iwamoto N; Yamazaki S; Fukuda T; Kondo M; Yamamoto N
    Nihon Naibunpi Gakkai Zasshi; 1986 Jun; 62(6):724-36. PubMed ID: 3758431
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum-25-hydroxycholecalciferol and renal osteodystrophy.
    Nielsen HE; Melsen F; Lund B; Sorensen OH; Christensen MS
    Lancet; 1977 Apr; 1(8014):754-5. PubMed ID: 66549
    [No Abstract]   [Full Text] [Related]  

  • 49. Proceedings: The use of metabolically-active derivatives of vitamin D in rickets and osteomalacia due to renal glomerular failure.
    Smith R; Henderson RG; Russell RG
    J Bone Joint Surg Br; 1975 May; 57(2):247-8. PubMed ID: 1141297
    [No Abstract]   [Full Text] [Related]  

  • 50. Vitamin D therapy: problems and prospects.
    Drug Ther Bull; 1975 Apr; 13(8):29-31. PubMed ID: 165927
    [No Abstract]   [Full Text] [Related]  

  • 51. [Use of vitamin D 2 and its metabolites in chronic glomerulonephritis in children].
    Naumova VI; Rusnak FI; Vereskova SA; Kutafina EK; Panchenko EL
    Pediatriia; 1989; (5):19-22. PubMed ID: 2671919
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Laboratory diagnosis of renal diseases. Modern views on the pathogenesis of uremic osteodystrophy. I].
    Jelonek A
    Przegl Lek; 1974; 31(8):758-62. PubMed ID: 4409945
    [No Abstract]   [Full Text] [Related]  

  • 53. Renal osteodystrophy in nondialysed adolescents. Long-term treatment with 1alpha-hydroxycholecalciferol.
    Kanis JA; Henderson RG; Heynen G; Ledingham JG; Russell RG; Smith R; Walton RJ
    Arch Dis Child; 1977 Jun; 52(6):473-81. PubMed ID: 879833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 55. How important is phosphate in the pathogenesis of renal osteodystrophy?
    Slatopolsky E; Rutherford WE; Hruska K; Martin K; Klahr S
    Arch Intern Med; 1978 May; 138 Spec No():848-52. PubMed ID: 646572
    [No Abstract]   [Full Text] [Related]  

  • 56. Renal osteodystrophy and its treatment.
    Duursma SA; Mees EJ
    Neth J Med; 1973; 16(2):101-7. PubMed ID: 4705764
    [No Abstract]   [Full Text] [Related]  

  • 57. [Vitamin D metabolism and chronic kidney insufficiency].
    Schaefer K; von Herrath D; Kraft D
    Dtsch Med Wochenschr; 1973 Jul; 98(27):1338-44. PubMed ID: 4351844
    [No Abstract]   [Full Text] [Related]  

  • 58. A model for clinical research studies of renal osteodystrophy in children.
    Norman ME; Mazur A; Gruskin AB
    Arch Intern Med; 1978 May; 138 Spec No():866-8. PubMed ID: 646576
    [No Abstract]   [Full Text] [Related]  

  • 59. [Pathogenesis, etiology and treatment of renal osteopathy].
    Raszeja-Wanic B; Kontek M
    Pol Tyg Lek; 1972 Sep; 27(37):1457-9. PubMed ID: 4344405
    [No Abstract]   [Full Text] [Related]  

  • 60. Comparative effect of 1alpha-hydroxycholecalciferol in children and adults with renal glomerular osteodystrophy.
    Henderson RG; Kanis JA; Ledingham JG; Oliver DO; Russel RG; Smith R; Walton RJ
    Calcif Tissue Res; 1976 Aug; 21 Suppl():221-5. PubMed ID: 782661
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.